Clinical trial
Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil…
NCT00064701 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00064701 |
|---|---|
| Title | Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients |
| Official title | A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (Cyclosporine)/MMF in de Novo Kidney Transplant Recipients |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Tacrolimus Modified Release (MR), Tacrolimus, cyclosporine microemulsion, mycophenolate mofetil |
| Enrollment | 668 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2009 |
| First posted | Jul 14, 2003 |
| Last update posted | Dec 5, 2013 |
| Countries | Brazil, Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: